Gonzalez-Nafria N, Rojo-Lopez A, Martinez-Velasco E, Gonzalez-Gonzalez D, de la Fuente-Bobillo M A, Tola-Arribas M A, Ortega-Valin F
Hospital Universitario Rio Hortega, Valladolid, Espana.
Hospital Universitario Rio Hortega, 47010 Valladolid, Espana.
Rev Neurol. 2019 Jul 1;69(1):27-31. doi: 10.33588/rn.6901.2018501.
Metronidazole is a widely known and used antibiotic. In exceptional cases, an encephalopathy with characteristic lesions on magnetic resonance imaging (MRI), usually located in the cerebellum and splenium of the corpus callosum, may be an adverse effect. The incidence and pathogenesis are unknown. The suspension of the treatment usually resolves the symptoms and normalizes the MRI in a few weeks. Due to the usual good prognosis, the anatomopathological findings are exceptional. We present a clinical case with the radiological findings suggestive of metronidazole-induced encephalopathy and, exceptionally, we provide the anatomopathological findings.
A 72 years-old woman with severe Crohn's disease who, months after starting treatment with metronidazole, presented a slowly progressing bradypsychia and difficulty walking until she came to coma. In MRI it showed hyperintense images in T2 in the corpus callosum, red and dentate nuclei. He improved by stopping metronidazole but later developed sepsis and died. At autopsy, softening of the red nucleus was observed and, microscopically, cell necrosis and demyelination.
With the publication of the clinical, radiological and anatomopathological information of our case we intend to promote the knowledge of this infrequent treatable cause of subacute encephalopathy and provide data that help to clarify its pathogenesis.
甲硝唑是一种广为人知且常用的抗生素。在极少数情况下,磁共振成像(MRI)上出现特征性病变的脑病,通常位于小脑和胼胝体压部,可能是其不良反应。其发病率和发病机制尚不清楚。停止治疗通常会在几周内使症状缓解且MRI恢复正常。由于通常预后良好,解剖病理学发现较为罕见。我们报告一例临床病例,其影像学表现提示甲硝唑诱发的脑病,并且特别地,我们提供了解剖病理学发现。
一名72岁患有严重克罗恩病的女性,在开始使用甲硝唑治疗数月后,出现了进展缓慢的精神迟钝和行走困难,直至昏迷。MRI显示胼胝体、红核和齿状核在T2加权像上呈高信号。停用甲硝唑后病情有所改善,但后来发生败血症并死亡。尸检时,观察到红核软化,显微镜下可见细胞坏死和脱髓鞘。
通过公布我们病例的临床、影像学和解剖病理学信息,我们旨在增进对这种罕见的可治疗的亚急性脑病病因的认识,并提供有助于阐明其发病机制的数据。